Actinogen Medical Limited

ACW.AX·ASX·Healthcare

Compare

0.0460+0.0010 (+2.22%)today

At close: Oct 19, 4:10 PM AEDT · May be delayed up to 20 min · AUD

Key statistics

Previous close0.0450

Open0.0450

Day range0.04300.0460

52-week range0.03000.0720

Off day high0.00%

Off 52-week high−36.11%

Volume2.27M

Avg. volume (3M)4.09M

Market cap178.21M

EPS (TTM)0.000000

Forward P/E-4.60

P/E ratio (TTM)—

Dividend yield—

Beta (5Y)0.83

Shares outstanding3.87B

Short interest—

Earnings dateAug 27, 2025 (est.)

Analyst target0.0800

Profit margin−121.35%

Against its peers

Compare in full ›

	ACW.AX	AVXL	ACTU	NMRA	XBIT	NGEN
Market cap	178.21M	121.43M	14.53M	89.03M	64.63M	170.96M
P/E (TTM)	—	—	—	—	—	—
Forward P/E	-4.6	-2.4	-0.9	-0.7	16.3	-4.7
Price/book	7.7	1.1	14.8	2.0	0.5	5.1
Dividend yield	—	—	—	—	—	—
1-year change	+45.16%	−86.00%	−91.81%	−73.81%	−14.52%	−48.04%
Today	+2.22%	−11.49%	+21.02%	+10.96%	−1.85%	−1.85%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.

Related companies

Compare ›

The businesses closest to ACW.AX's by what they do, from their descriptions, with the same industry weighted in.

Company	Mkt cap	Price	Today
Anavex Life Sciences Corp.AVXL · Biotechnology	121.43M	1.3100	−11.49%
Actuate Therapeutics, Inc. Common stockACTU · Biotechnology	14.53M	0.6050	+21.02%
Neumora Therapeutics, Inc.NMRA · Biotechnology	89.03M	0.4738	+10.96%
XBiotech Inc.XBIT · Biotechnology	64.63M	2.1200	−1.85%
NervGen Pharma Corp.NGEN · Biotechnology	170.96M	1.5900	−1.85%
Alector, Inc.ALEC · Biotechnology	205.45M	1.8400	−3.66%
Solid Biosciences Inc.SLDB · Biotechnology	592.96M	5.53	−3.66%
Vanda Pharmaceuticals Inc.VNDA · Biotechnology	243.66M	4.0300	−4.95%

What visitors to ACW.AX's page also look at.

Company	Mkt cap	Price	Today
IMUGENE FPO [IMU]IMU.AX	20.09M	0.0360	+5.88%
ANTEO TECH FPO [ADO]ADO.AX	48.98M	0.0150	0.00%
PRESCIENT FPO [PTX]PTX.AX	66.34M	0.0580	−4.92%
DIMERIX FPO [DXB]DXB.AX	132.09M	0.2200	+4.76%
CYNATA THR FPO [CYP]CYP.AX	2.68M	0.0110	0.00%

From the 4Search instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All ACW.AX news ›

Kalkine·5d agoNegative

Actinogen Medical Limited (ASX:ACW): How Brain Cortisol Research Shapes Its Alzheimer’s Trial

Xanamem remains an investigational therapy and is not approved for routine medical use. The mechanism provides a scientific rationale for research; any claim about clinical effectiveness must be established through trial results. In August…

From articles in the 4Search news index.

In the news

3mentions in 30 days

3with it in the headline

Negativesentiment

Most coverage from

kalkine.com.au1
pluang.com1
proactiveinvestors.com1

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 3 articles, not a forecast.

About

Profile ›

Actinogen Medical Limited, a biotechnology company, develops therapies for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol in Australia. It develops Xanamem, an oral medication and inhibitor of the 11ß-HSD1 enzyme that achieves target engagement in the brain for the treatment of Alzheimer's disease, major depressive disorder, fragile x syndrome, and other neurological diseases. The company was formerly known as Actinogen Limited and changed its name to Actinogen Medical Limite…

SectorHealthcare

IndustryBiotechnology

Chief executiveSteven G. Gourlay ), FRACP, M.B.A., MBBS (M.D., Ph.D.

HeadquartersSydney, NSW, Australia

Websiteactinogen.com.au

Analyst ratings

Analysis ›

—1 analysts

Strong buy 1
Buy 0
Hold 0
Sell 0
Strong sell 0

Wall Street analyst consensus. Not a recommendation.

Earnings

Reported EPS
Estimate

Next report: Wed, Aug 27, 2025 (estimated)

Quarterly results

Financials ›

Revenue
Net income

Prices may be delayed up to 15 min. Not investment advice.

Track record

Leaderboard ›

Days on the list	30 d	1 yr	Best
Trending	0	0	—

Not eligible for Gainers, Losers, Most active (U.S. stocks worth $2 billion or more only).

Not eligible for Small-cap gainers, Aggressive small caps (U.S. stocks worth under $2 billion only).

Not eligible for Growth tech (U.S. technology stocks only).

Not eligible for Undervalued large caps (U.S. stocks worth $10 billion or more only).

A day counts when it ranked in the top 25 of a list. Tracked since Oct 10, 2026.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.